Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients without prior polymerase chain reaction–confirmed COVID-19
were recruited from across the US to participate in this prospective cohort through a digital …

Foot strike patterns and collision forces in habitually barefoot versus shod runners

DE Lieberman, M Venkadesan, WA Werbel, AI Daoud… - Nature, 2010 - nature.com
Humans have engaged in endurance running for millions of years 1, but the modern running
shoe was not invented until the 1970s. For most of human evolutionary history, runners …

Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients

BJ Boyarsky, WA Werbel, RK Avery, AAR Tobian… - Jama, 2021 - jamanetwork.com
Methods| Transplant recipients across the US were recruited though social media to participate
in this prospective cohort, and those who underwent SARS-CoV-2 vaccination between …

Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series

WA Werbel, BJ Boyarsky, MT Ou… - Annals of internal …, 2021 - acpjournals.org
Background: The antibody response after 2 doses of an mRNA vaccine against SARS-CoV-2
is excellent in the general population (1), but the response is different in recipients of solid …

Early impact of COVID‐19 on transplant center practices and policies in the United States

…, T Po‐Yu Chiang, WA Werbel… - american Journal of …, 2020 - Wiley Online Library
COVID‐19 is a novel, rapidly changing pandemic: consequently, evidence‐based
recommendations in solid organ transplantation (SOT) remain challenging and unclear. To …

Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients

…, M Malinis, S Aslam, E Todesco, WA Werbel… - …, 2021 - journals.lww.com
All authors participated in conception or design of the work or the acquisition, analysis, or
interpretation of data for the work; drafting the work or revising it critically for important …

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases

…, JA Ruddy, CM Connolly, MT Ou, WA Werbel… - Annals of the …, 2021 - ard.bmj.com
The immune response to SARS-CoV-2 messenger RNA (mRNA) vaccines in patients with
rheumatic and musculoskeletal diseases (RMD) is undefined because these individuals were …

Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two‐dose SARS–CoV‐2 messenger RNA vaccination

…, BJ Boyarsky, I Barbur, WA Werbel… - Arthritis & …, 2022 - Wiley Online Library
Objective To evaluate disease flare and postvaccination reactions (reactogenicity) in
patients with rheumatic and musculoskeletal diseases (RMDs) following 2‐dose SARS–CoV‐2 …

Antibody response to a fourth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series

…, JM Garonzik-Wang, DL Segev, WA Werbel - …, 2021 - journals.lww.com
The antibody response after 2 doses of an mRNA severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine is excellent in the general population but less robust in …

A third dose of SARS‐CoV‐2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

…, DL Segev, AAR Tobian, WA Werbel - American Journal of …, 2022 - Wiley Online Library
Vaccine‐induced SARS‐CoV‐2 antibody responses are attenuated in solid organ transplant
recipients (SOTRs) and breakthrough infections are more common. Additional SARS‐CoV‐…